Guardant Health Inc- 詳細介紹、公司背景、業務範圍、財務數據以及市場表現

關於 Guardant Health Inc 公司

Guardant Health, Inc. 是一家精準腫瘤學公司，致力於守護健康並讓每個人有更多時間遠離癌症。該公司通過先進的血液和組織測試、真實世界數據和人工智能 (AI) 分析，提供有關疾病驅動因素的關鍵見解。Guardant 測試有助於改善所有護理階段的結果，包括篩查以儘早發現癌症、監測早期癌症的復發以及幫助醫生爲晚期癌症患者選擇最佳治療方法。對於晚期癌症患者，該公司開發了 Guardant360 實驗室開發測試 (LDT) 和 Guardant360 CDx，這是一種全面的液體活檢測試，可爲實體腫瘤提供腫瘤突變分析，並可用作非小細胞肺癌 (NSCLC) 和乳腺癌的伴隨診斷。該公司還提供其他測試，包括 Guardant360 TissueNext 組織測試、Guardant Reveal 血液測試、Guardant360 Response 血液測試等。

Guardant Health Inc簡介



公司代碼GH

公司名稱Guardant Health Inc

上市日期Oct 04, 2018

CEODr. Amirali Talasaz, Ph.D.

員工數量1999

證券類型Ordinary Share

年結日Oct 04

公司地址3100 Hanover Street

城市PALO ALTO

上市交易所NASDAQ Global Select Consolidated

國家United States of America

郵編94304

電話18556988887

網址https://guardanthealth.com/

公司代碼GH

上市日期Oct 04, 2018

CEODr. Amirali Talasaz, Ph.D.

Guardant Health Inc公司高管



名稱

名稱/職務

職務

持股

持股變動

Dr. Amirali Talasaz, Ph.D.

Co-Chief Executive Officer, Director

2.52M

+0.47%

Dr. Helmy A. Eltoukhy, Ph.D.

Chairperson of the Board, Co-Chief Executive Officer

2.47M

+0.48%

Dr. Darya Chudova

Chief Technology Officer

88.53K

+9.85%

Mr. John Gomes Saia

Chief Legal Officer, Corporate Secretary

52.17K

+14.83%

Mr. Craig Eagle, M.D.

Chief Medical Officer

44.32K

+18.23%

Ms. Vijaya V. Gadde

Independent Director

24.31K

+37.83%

Mr. Kumud Kalia

Chief Information Officer

21.68K

+31.56%

Ms. Myrtle Stephens Potter

Independent Director

18.28K

+0.23%

Ms. Meghan V. Joyce

Independent Director

11.18K

-0.89%

Mr. Musa Tariq

Independent Director

7.59K

+1.78%

名稱

名稱/職務

職務

持股

持股變動

Dr. Amirali Talasaz, Ph.D.

Co-Chief Executive Officer, Director

2.52M

+0.47%

Dr. Helmy A. Eltoukhy, Ph.D.

Chairperson of the Board, Co-Chief Executive Officer

2.47M

+0.48%

Dr. Darya Chudova

Chief Technology Officer

88.53K

+9.85%

Mr. John Gomes Saia

Chief Legal Officer, Corporate Secretary

52.17K

+14.83%

Mr. Craig Eagle, M.D.

Chief Medical Officer

44.32K

+18.23%

Ms. Vijaya V. Gadde

Independent Director

24.31K

+37.83%

收入明細

單位: USD更新時間: 7 小時前

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

業務USD

名稱

營收

佔比

Oncology

158.69M

68.37%

Biopharma and data

56.02M

24.14%

Screening

14.81M

6.38%

Licensing and other

2.57M

1.11%

地區USD

名稱

營收

佔比

United States

216.68M

93.36%

International

15.40M

6.64%

業務

地區

業務USD

名稱

營收

佔比

Oncology

158.69M

68.37%

Biopharma and data

56.02M

24.14%

Screening

14.81M

6.38%

Licensing and other

2.57M

1.11%

股東統計

更新時間: 9月28日週日

持股股東

股東類型

持股股東

佔比

The Vanguard Group, Inc.

9.74%

BlackRock Institutional Trust Company, N.A.

6.73%

Capital International Investors

3.99%

Baillie Gifford & Co.

3.86%

Deep Track Capital LP

3.41%

其他

72.28%

持股股東

佔比

The Vanguard Group, Inc.

9.74%

BlackRock Institutional Trust Company, N.A.

6.73%

Capital International Investors

3.99%

Baillie Gifford & Co.

3.86%

Deep Track Capital LP

3.41%

其他

72.28%

股東類型

持股股東

佔比

Investment Advisor

45.84%

Investment Advisor/Hedge Fund

27.21%

Hedge Fund

19.41%

Individual Investor

4.36%

Bank and Trust

2.25%

Sovereign Wealth Fund

1.83%

Research Firm

1.74%

Pension Fund

1.17%

Family Office

0.03%

機構持股



更新時間: 10月1日週三

報告期間

機構數

持股數

持股佔比

持股變動

2025Q3

750

124.14M

99.55%

-16.44M

2025Q2

759

134.16M

107.59%

-14.14M

2025Q1

783

130.34M

105.23%

-16.59M

2024Q4

746

130.16M

105.47%

-20.09M

2024Q3

780

137.29M

111.53%

-9.70M

2024Q2

801

127.50M

103.74%

-18.45M

2024Q1

826

124.00M

101.88%

-12.71M

2023Q4

856

120.18M

99.30%

-14.26M

2023Q3

867

117.78M

100.31%

-19.15M

2023Q2

890

119.83M

102.55%

+840.96K

股東持股明細



名稱

持股數

佔比

持股變動

變動比例

公告日期

The Vanguard Group, Inc.

12.14M

9.74%

+89.50K

+0.74%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

8.39M

6.73%

-215.41K

-2.50%

Jun 30, 2025

Capital International Investors

4.98M

3.99%

-171.27K

-3.33%

Jun 30, 2025

Baillie Gifford & Co.

4.81M

3.86%

-251.22K

-4.96%

Jun 30, 2025

Deep Track Capital LP

4.25M

3.41%

-1.19M

-21.93%

Jun 30, 2025

Two Sigma Investments, LP

4.24M

3.4%

+42.75K

+1.02%

Jun 30, 2025

Eventide Asset Management, LLC

3.46M

2.77%

-107.78K

-3.02%

Jun 30, 2025

Invesco Advisers, Inc.

3.40M

2.73%

+789.69K

+30.20%

Jun 30, 2025

Cadian Capital Management LP

3.18M

2.55%

-1.42M

-30.81%

Jun 30, 2025

Citadel Advisors LLC

2.94M

2.36%

-658.36K

-18.30%

Jun 30, 2025

持股ETF



更新時間: 17 小時前

機構名稱

佔比

Global X Genomics & Biotechnology ETF

5.38%

ARK Genomic Revolution ETF

5.3%

Franklin Genomic Advancements ETF

5.28%

First Trust Nasdaq Lux Digi Health Solutions ETF

3.58%

Invesco Dorsey Wright Healthcare Momentum ETF

3.15%

SPDR S&P Health Care Services ETF

2.68%

Alger Mid Cap 40 ETF

2.55%

ROBO Global Healthcare Technology & Innovation ETF

2.47%

iShares Health Innovation Active ETF

1.92%

iShares U.S. Healthcare Providers ETF

1.37%

Global X Genomics & Biotechnology ETF

佔比5.38%

ARK Genomic Revolution ETF

佔比5.3%

Franklin Genomic Advancements ETF

佔比5.28%

First Trust Nasdaq Lux Digi Health Solutions ETF

佔比3.58%

Invesco Dorsey Wright Healthcare Momentum ETF

佔比3.15%

SPDR S&P Health Care Services ETF

佔比2.68%

Alger Mid Cap 40 ETF

佔比2.55%

ROBO Global Healthcare Technology & Innovation ETF

佔比2.47%

iShares Health Innovation Active ETF

佔比1.92%

iShares U.S. Healthcare Providers ETF

佔比1.37%

分紅派息



近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股



公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據